Annotation Detail

Information
Associated Genes
EGFR
Associated Variants
EGFR EXPRESSION
EGFR EXPRESSION
Associated Disease
head and neck squamous cell carcinoma
Source Database
CIViC Evidence
Description
47 HNSCC patients treated with cetuximab/docetaxel were retrospectively analyzed for EGFRvIII, EGFR and AREG expression with IHC. 73 % of cases expressed high level of EGFRvIII. EGFR expression had no impact on PFS or OS.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/849
Gene URL
https://civic.genome.wustl.edu/links/genes/19
Variant URL
https://civic.genome.wustl.edu/links/variants/354
Rating
3
Evidence Type
Predictive
Disease
Head And Neck Squamous Cell Carcinoma
Evidence Direction
Does Not Support
Drug
Docetaxel,Cetuximab
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
21653686
Drugs
Drug NameSensitivitySupported
CetuximabSensitivityfalse
DocetaxelSensitivityfalse